Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Adial Pharmaceuticals Inc WT (ADILW)

Adial Pharmaceuticals Inc WT (ADILW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Adial Pharmaceuticals Announces Topline Results For Onward™ Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder Globe Newswire - Wed Jul 20, 2022

AD04 achieved statistically significant mean reduction in heavy drinking days among pre-specified group of heavy drinkers, compared to placebo, with an...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)
Adial Pharmaceuticals to Announce Topline Results of ONWARD™ Phase 3 Trial for AD04 in Patients With Alcohol Use Disorder Globe Newswire - Mon Jul 18, 2022

Company to host conference call on Wednesday, July 20, 2022, at 1 PM ET...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)
Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley Globe Newswire - Tue Jun 28, 2022

CHARLOTTESVILLE, Va., June 28, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today issued the...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial Globe Newswire - Mon Jun 27, 2022

Expects Release of Top-Line Data in July...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial Globe Newswire - Mon Jun 27, 2022

Expects Release of Top-Line Data in July...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)
Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence Globe Newswire - Tue Jun 14, 2022

New patent covers the use of the full genetic panel measuring all five genetic biomarkers...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)
Adial Pharmaceuticals Announces Research Collaboration with the Medical College of Wisconsin to Advance Purnovate’s Adenosine Compounds as Potential Treatments for Diabetes and NASH Globe Newswire - Thu May 19, 2022

CHARLOTTESVILLE, Va., May 19, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today announced that...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)
Adial Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results Globe Newswire - Mon May 16, 2022

Nears completion of ONWARD™ Phase 3 pivotal trial of AD04 for the treatment of Alcohol Use Disorder; on track to report Phase 3 results in the current...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)
Adial Pharmaceuticals Announces Research Collaboration with UC San Diego to Advance Purnovate’s Adenosine Compounds as Potential Treatments for Inflammatory Diseases & Disorders Globe Newswire - Wed May 4, 2022

CHARLOTTESVILLE, Va., May 04, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today announced that...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)
Adial Pharmaceuticals CEO to Participate in a Fireside Chat at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th Globe Newswire - Tue Mar 22, 2022

CHARLOTTESVILLE, Va., March 22, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage...

ADIL : 1.93 (-11.06%)
ADILW : 0.0009 (-57.14%)

Barchart Exclusives

Dividend Newcomers: Discover 3 Companies Starting To Share the Wealth Barchart - Fri Apr 19, 6:00PM CDT
Discover the potential of newly initiated dividends—start building your wealth with tomorrow's top dividend payers today! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot